» Articles » PMID: 22631642

Risk Factors of Hepatocellular Carcinoma--current Status and Perspectives

Overview
Specialty Oncology
Date 2012 May 29
PMID 22631642
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatocellular carcinoma is a common disorder worldwide which ranks 5th and 7th most common cancer among men and women. In recent years, different incidence trends have been observed in various regions, but the reasons are not completely understood. However, due to the great public efforts in HCC prevention and alternation of lifestyle, the roles of some well documented risk factors played in hepatocarcinogenesis might have changed. This paper summarizes both the environmental and host related risk factors of hepatocellular carcinoma including well established risk factors such as hepatitis virus infection, aflatoxin and alcohol, as well as possible risk factors such as coffee drinking and other dietary agents.

Citing Articles

Demographic Profile and Etiology of Hepatocellular Carcinoma in Zaria, Northern Nigeria.

Manko M, Mohammed M, Ahmed M, Bello A, Egbegbedia P, Abdullahi U Niger Med J. 2024; 63(4):282-287.

PMID: 38863473 PMC: 11163258. DOI: 10.60787/NMJ-63-4-74.


Metabolic Dysfunction-Associated Steatohepatitis and Progression to Hepatocellular Carcinoma: A Literature Review.

Ghazanfar H, Javed N, Qasim A, Sarin Zacharia G, Ghazanfar A, Jyala A Cancers (Basel). 2024; 16(6).

PMID: 38539547 PMC: 10969013. DOI: 10.3390/cancers16061214.


Distinctive Metabolism-Associated Gene Clusters That Are Also Prognostic in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma.

Ding L, Ning S, Hu W, Xue Y, Yu S Oxid Med Cell Longev. 2022; 2022:6595989.

PMID: 36199423 PMC: 9527115. DOI: 10.1155/2022/6595989.


Liver Disease Outcomes after Sustained Virological Response in Patients with Chronic Hepatitis C Infection Treated with Generic Direct-Acting Antivirals.

Abd El-Wahab E, Elgawad W, Abdelaziz M, Mikheal A, Shatat H Am J Trop Med Hyg. 2022; .

PMID: 35226870 PMC: 9128674. DOI: 10.4269/ajtmh.21-0918.


Anticancer effects of imidazole nucleus in hepatocellular carcinoma cell lines via the inhibition of AKT and ERK1/2 signaling pathways.

Kahraman E, Goker E Mol Biol Rep. 2022; 49(6):4377-4388.

PMID: 35226260 DOI: 10.1007/s11033-022-07273-9.